SynthesisClinical drug investigation2024

Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches.

Jeffrey H LiptonPubMed ↗Publisher ↗

No numbers read from the abstract.